EMD-36934

Single-particle
3.07 Å
EMD-36934 Deposition: 26/07/2023
Map released: 15/05/2024
Last modified: 15/05/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-36934

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Local map of SV2A LD4-BoNT/A2 Hc from SV2A-BoNT/A2 Hc-brivaracetam complex

EMD-36934

Single-particle
3.07 Å
EMD-36934 Deposition: 26/07/2023
Map released: 15/05/2024
Last modified: 15/05/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Clostridium botulinum
Sample: Synaptic vesicle glycroprotein 2A in complex with brivaracetam and botulinum neurotoxin A2 Hc domain

Deposition Authors: Yamagata A
Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A.
Yamagata A , Ito K, Suzuki T , Dohmae N , Terada T , Shirouzu M
(2024) Nat Commun , 15 , 3027 - 3027
PUBMED: 38637505
DOI: doi:10.1038/s41467-024-47322-4
ISSN: 2041-1723